| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/20/2007 | US20070219179 Indole Derivative Having Piperidine Ring |
| 09/20/2007 | US20070215844 Chromene Compound |
| 09/20/2007 | CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | CA2646235A1 Non-peptidic renin inhibitors nitroderivatives |
| 09/20/2007 | CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | CA2643962A1 Antibiotic compounds |
| 09/20/2007 | CA2643859A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | CA2643066A1 Pyrazole compounds |
| 09/20/2007 | CA2643055A1 Tetralines antagonists of the h-3 receptor |
| 09/19/2007 | EP1834953A1 Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1834944A1 Process for preparing C7 intermediates and their use in the preparation on N-substituted pyrrole derivatives |
| 09/19/2007 | EP1833824A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 09/19/2007 | EP1833816A1 Substituted piperidines as renin inhibitors |
| 09/19/2007 | EP1833802A2 1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 09/19/2007 | EP1833797A1 Azacyclic compounds as inhbitors of sensory neurone specific channels (sns) |
| 09/19/2007 | EP1638959B1 5ht -4 -antagonistic 4-(aminomethyl)-piperidine benzamides |
| 09/19/2007 | EP1425011A4 Enhancement of learning and memory and treatment of amnesia |
| 09/19/2007 | EP1198456B1 Potassium channel openers |
| 09/19/2007 | CN101039941A Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
| 09/19/2007 | CN101039935A New piperidine antibiotics |
| 09/19/2007 | CN101039934A 1,5-diheterocycle-1H-triazole derivative |
| 09/19/2007 | CN101039933A Diaminotriazole compounds useful as protein kinase inhibitors |
| 09/19/2007 | CN101039912A Pyridine derivatives and the preparation and the therapeutic use thereof |
| 09/19/2007 | CN101039907A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 09/19/2007 | CN101039904A Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 09/19/2007 | CN101037413A Pyrezole compound or medicinal salt and medicine composition |
| 09/19/2007 | CN100338060C Novel use of substituted aminomethyl chromans |
| 09/19/2007 | CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 09/19/2007 | CN100337751C Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/18/2007 | US7271270 High affinity small molecule C5a receptor modulators |
| 09/18/2007 | US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 09/18/2007 | US7271261 Useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2) |
| 09/18/2007 | US7271193 Inhibitors of cyclin-dependent kinases and their use |
| 09/18/2007 | US7271192 Nitrogen oxide synthase inhibitors; synthesis |
| 09/18/2007 | US7271190 Indazole compounds as β3 adrenoceptor agonist |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271180 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/18/2007 | US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 09/18/2007 | US7271168 Piperazine derivatives having SST1 antagonistic activity |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 09/18/2007 | CA2221991C Di- and trivalent small molecule selectin inhibitors |
| 09/18/2007 | CA2220533C 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them |
| 09/18/2007 | CA2201812C 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
| 09/18/2007 | CA2095797C Arylacetamides |
| 09/13/2007 | WO2007102580A1 Polycyclic cinnamide derivative |
| 09/13/2007 | WO2007102368A1 Novel 3-(1-aminoalkylidene)furan-2,4(3h,5h)-dione derivative, method for producing the same, and pharmaceutical composition containing the same as active ingredient |
| 09/13/2007 | WO2007102059A1 Sulfonyl benzimidazole derivatives |
| 09/13/2007 | WO2007101347A1 Bir domain binding compounds |
| 09/13/2007 | WO2007087488A3 Indole sulfonamide modulators of progesterone receptors |
| 09/13/2007 | WO2007087419A3 Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| 09/13/2007 | WO2007051333A8 Triazine beta-secretase inhibitors |
| 09/13/2007 | US20070213519 Building Block Forming A C=C Double Bond Upon Reaction |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands |
| 09/13/2007 | US20070213369 Novel non-psychotropic cannabinoids |
| 09/13/2007 | US20070213367 Substituted 3-cyanoquinolines as MEK inhibitors |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070213346 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists |
| 09/13/2007 | US20070213345 Immuno Inhibitory Pyrazolone Compounds |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213319 Inflammatory diseases and dysproliferative diseases such as rheumatoid arthritis, cancer; N2-(2-(phenylthiobenzyl)-2,4-diamino-quinazolines |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070212297 Amino methyl imidazoles and related compounds as C5a receptor modulators |
| 09/13/2007 | CA2643796A1 Polycyclic cinnamide derivatives |
| 09/12/2007 | EP1831203A1 Chroman derivatives and uses thereof in the treatment of cns disorders |
| 09/12/2007 | EP1831194A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 09/12/2007 | EP1831191A1 Chroman derivatives and their use as 5-ht receptor ligands |
| 09/12/2007 | EP1831185A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 09/12/2007 | EP1831174A1 Amide derivatives |
| 09/12/2007 | EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 09/12/2007 | EP1831153A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
| 09/12/2007 | EP1737840B1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 09/12/2007 | EP1682528B1 BENZO [b][1,4] DIOXEPINE DERIVATIVES |
| 09/12/2007 | EP1558579B1 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials |
| 09/12/2007 | EP1444201B1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 09/12/2007 | EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP1301480B1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 09/12/2007 | CN101035785A Novel compounds having an anti-bacterial activity |
| 09/12/2007 | CN101035783A Urea derivatives as calcium channel blockers |
| 09/12/2007 | CN101035769A Pyrimidine urea derivatives as kinase inhibitors |
| 09/12/2007 | CN101035768A Compounds and compositions useful as cathepsin S inhibitors |
| 09/12/2007 | CN100336809C Peptide deformylase inhibitors |
| 09/11/2007 | US7268232 Androgen receptor modulators and method of treating disease using the same |
| 09/11/2007 | US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268134 Medical devices employing triazine compounds and compositions thereof |
| 09/11/2007 | US7268111 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 09/11/2007 | CA2432064C Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/07/2007 | WO2007101213A2 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 09/07/2007 | WO2007100880A1 Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors |
| 09/07/2007 | WO2007100852A1 Therapeutic piperazines as pde4 inhibitors |